Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

Hidekazu Shirota; Dennis M. Klinman

doi:10.2217/imt.13.70

Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

Hidekazu Shirota, Dennis M. Klinman

Medicine

Research output: Contribution to journal › Review article › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	787-789
Number of pages	3
Journal	Immunotherapy
Volume	5
Issue number	8
DOIs	https://doi.org/10.2217/imt.13.70
Publication status	Published - 2013 Aug

Keywords

CpG oligonucleotide
Toll-like receptor 9
cancer immunotherapy
myeloid-derived suppressor cell

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/imt.13.70

Cite this

@article{893448bbe24e4c20b36272c5bcd7fbf6,

title = "Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment",

keywords = "CpG oligonucleotide, Toll-like receptor 9, cancer immunotherapy, myeloid-derived suppressor cell",

author = "Hidekazu Shirota and Klinman, {Dennis M.}",

year = "2013",

month = aug,

doi = "10.2217/imt.13.70",

language = "English",

volume = "5",

pages = "787--789",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "Future Medicine Ltd.",

number = "8",

}

TY - JOUR

T1 - Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

AU - Shirota, Hidekazu

AU - Klinman, Dennis M.

PY - 2013/8

Y1 - 2013/8

KW - CpG oligonucleotide

KW - Toll-like receptor 9

KW - cancer immunotherapy

KW - myeloid-derived suppressor cell

UR - http://www.scopus.com/inward/record.url?scp=84881295741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881295741&partnerID=8YFLogxK

U2 - 10.2217/imt.13.70

DO - 10.2217/imt.13.70

M3 - Review article

C2 - 23902544

AN - SCOPUS:84881295741

VL - 5

SP - 787

EP - 789

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 8

ER -

Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this